Patrick Lamy, Senior VP, Commercial Strategy at Akero Therapeutics, Inc. (AKRO), sold 4,000 shares at $50.00 ($200K) on 2025-05-22, disclosed to the SEC on 2025-05-23.
Scheduled sale ($200k) by Senior VP, Commercial Strategy under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| AKRO | SELL | 2025-06-20 | $108K | — | Filing → |
| AKRO | SELL | 2025-06-12 | $50K | — | Filing → |
| AKRO | SELL | 2025-06-04 | $201K | — | Filing → |